(Q39352950)

11 September 2017

title

Uptake routes of tumor-antigen MAGE-A3 by dendritic cells determine priming of naïve T-cell subtypes (English)

1 reference

11 September 2017

1 reference

4

1 reference

11 September 2017

Ines Moeller

1

1 reference

11 September 2017

Giulio C Spagnoli

series ordinal

2

1 reference

11 September 2017

Jürgen Finke

series ordinal

3

1 reference

11 September 2017

Leonora Houet

series ordinal

5

1 reference

11 September 2017

publication date

6 May 2012

1 reference

Cancer Immunology, Immunotherapy

11 September 2017

published in

1 reference

11 September 2017

volume

61

1 reference

11 September 2017

issue

11

1 reference

11 September 2017

page(s)

2079-2090

1 reference

https://scigraph.springernature.com/pub.10.1007/s00262-012-1272-y

11 September 2017

exact match

0 references

cites work

T cell defined tumor antigens

1 reference

https://api.crossref.org/works/10.1007%2FS00262-012-1272-Y

Longitudinal analysis and prognostic effect of cancer-testis antigen expression in multiple myeloma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-012-1272-Y

MAGE-A, mMage-b, and MAGE-C proteins form complexes with KAP1 and suppress p53-dependent apoptosis in MAGE-positive cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-012-1272-Y

MAGE-A1 interacts with adaptor SKIP and the deacetylase HDAC1 to repress transcription

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-012-1272-Y

MAGE-A tumor antigens target p53 transactivation function through histone deacetylase recruitment and confer resistance to chemotherapeutic agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-012-1272-Y

Mage-A cancer/testis antigens inhibit p53 function by blocking its interaction with chromatin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-012-1272-Y

Booster vaccination of cancer patients with MAGE-A3 protein reveals long-term immunological memory or tolerance depending on priming

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-012-1272-Y

Estimation of the frequencies of anti-MAGE-3 cytolytic T-lymphocyte precursors in blood from individuals without cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-012-1272-Y

GSK's antigen-specific cancer immunotherapy programme: pilot results leading to Phase III clinical development

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-012-1272-Y

Tumor antigen processing and presentation depend critically on dendritic cell type and the mode of antigen delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-012-1272-Y

Antitumor monoclonal antibodies enhance cross-presentation ofcCellular antigens and the generation of myeloma-specific killer T cells by dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-012-1272-Y

Pattern recognition receptors in the immune response against dying cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-012-1272-Y

Bortezomib enhances dendritic cell (DC)-mediated induction of immunity to human myeloma via exposure of cell surface heat shock protein 90 on dying tumor cells: therapeutic implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-012-1272-Y

Allogeneic HLA-matched donor dendritic cells loaded with patient leukemic blasts preferentially induce CD4-positive leukemia-reactive donor lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-012-1272-Y

Tumor-specific shared antigenic peptides recognized by human T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-012-1272-Y

Identification of immunodominant regions among promiscuous HLA-DR-restricted CD4+ T-cell epitopes on the tumor antigen MAGE-3

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-012-1272-Y

Cancer-testis antigens are commonly expressed in multiple myeloma and induce systemic immunity following allogeneic stem cell transplantation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-012-1272-Y

TCR vaccines against a murine T cell lymphoma: a primary role for antibodies of the IgG2c class in tumor protection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-012-1272-Y

Fcgamma receptors as regulators of immune responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-012-1272-Y

Two mechanisms of the enhanced antibody-dependent cellular cytotoxicity (ADCC) efficacy of non-fucosylated therapeutic antibodies in human blood

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-012-1272-Y

CD91 is a common receptor for heat shock proteins gp96, hsp90, hsp70, and calreticulin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-012-1272-Y

Cell surface expression of an endoplasmic reticulum resident heat shock protein gp96 triggers MyD88-dependent systemic autoimmune diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-012-1272-Y

10.1007/S00262-012-1272-Y

21 January 2018

Identifiers

DOI

1 reference

11 September 2017

1 reference